vancomycin has been researched along with Purpura Fulminans in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, A; Sharma, V | 1 |
| Fitzgerald, CJ; Givner, LB; Mou, S; Pranikoff, TV; Ross, GA; Shetty, AK | 1 |
2 other study(ies) available for vancomycin and Purpura Fulminans
| Article | Year |
|---|---|
From the toe to the head: metastatic endophalmitis following staphylococcal purpura fulminans.
Topics: Adult; Anti-Bacterial Agents; Endophthalmitis; Humans; Male; Purpura Fulminans; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Toes; Treatment Outcome; Vancomycin | 2014 |
Purpura fulminans caused by community-associated methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Child, Preschool; Clindamycin; Drug Therapy, Combination; Emergency Service, Hospital; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Purpura Fulminans; Staphylococcal Infections; Vancomycin | 2012 |